黑料不打烊

Global Medical Gases And Equipment Market Trends and Insights

Rapid Rise in Chronic Respiratory Diseases

Global COPD and asthma cases climbed to 569.2 million in 2025, yet age-standardized COPD mortality declined 30% between 2000 and 2019.^{[1]World Health Organization, 鈥淐hronic Obstructive Pulmonary Disease,鈥� who.int} Longer survival is driving millions of dollars into continuous home oxygen therapy, especially in regions with limited refill infrastructure. Europe logged 81.7 million respiratory cases in 2024, with COPD representing 32 million. South Asian and African patients experience an earlier onset due to indoor biomass smoke exposure, pushing governments to subsidize stationary and portable concentrators.

Aging Population Boosting Long-Term Oxygen Therapy

People aged 65 years and older accounted for 10% of the world's population in 2024 and will reach 16% by 2050.^{[2]United Nations, 鈥淲orld Population Aging,鈥� un.org} A 2024 meta-analysis showed that using oxygen for more than 15 hours daily extends hypoxemic COPD survival by 3.5 years. Japan expanded coverage for nocturnal oxygen therapy in 2025, adding roughly 120,000 eligible patients. Lightweight 2-kilogram devices with 8-hour batteries improve adherence among frail seniors and underpin growth in the medical gases and equipment market.

Expansion of Surgical & Diagnostic Procedures

U.S. robotic-assisted surgeries grew 8.3% year-over-year in 2025, and each procedure consumes 50-100 liters of medical-grade CO鈧� and ancillary anesthetic gases. Ambulatory surgical centers performed 28 million cases in 2025 after new CMS coverage additions. MRI scans still rely on liquid helium, but helium-free magnets from Siemens Healthineers slash per-scan helium use by 95%.

Home-Healthcare Shift Driving Portable Equipment Demand

Bundled ASC payments push hospitals to discharge patients with portable concentrators, stimulating a 34% rise in tele-monitored home oxygen users in 2025. The FDA cleared 47 sub-2-kilogram concentrators in 2025, and reimbursement rose 3.2% under the 2026 DME fee schedule. Telemedicine platforms cut emergency visits by 18%, validating the economic case for remote monitoring.

Stringent Purity & Safety Regulations

USP and Ph.Eur. require 99.5% oxygen purity and moisture below 67 ppm, forcing hospitals to install inline analyzers that cost USD 15,000-25,000 each. Quarterly pipeline testing adds USD 8,000-12,000 in annual overhead for a 200-bed facility. Divergent rules between China鈥檚 NMPA and overseas markets add up to USD 80,000 per product line and six-month delays, slowing new device launches.

Global Helium Shortage Affecting Specialty Gases

BLM reserve depletion doubled spot prices to USD 15 per cubic meter in 2025. MRI refill costs now reach USD 18,000 per magnet. France issued allocation rules that prioritize NICU cases, constraining adult access.^{[3]Agence Nationale de S茅curit茅 du M茅dicament, 鈥淗elium Allocation Guidelines,鈥� ansm.sante.fr} New supply from Qatar and Russia may ease shortages post-2027, but geopolitical risks keep Western buyers exposed.

Segment Analysis

By Product Type: Medical Gases Sustain Revenue Momentum

Medical gases generated 56.02% of the medical gases and equipment market revenue in 2025, and this segment is forecast to grow at 7.87% annually through 2031. Persistent COPD therapy, wider helium demand in imaging, and PSA cost advantages keep consumption recurring even as reimbursement tightens. In contrast, equipment sales lag because pipelines, manifolds, and monitors last 15-20 years and are increasingly bundled into procedural payments. Nonetheless, IoT-enabled manifolds are extending service revenue and anchoring buyers to premium brands, a dynamic that supports overall expansion of the medical gases and equipment market.

Specialty gases such as nitrous oxide, carbon dioxide, and medical air command premium prices due to purity controls. Nitrous oxide must reach 99% purity, whereas medical air compressors must achieve 鈥�40 掳C dew points. Suppliers are embedding predictive maintenance sensors that cut downtime 25% and push hospitals toward multiyear service contracts. Those advances sustain margins even as competitive bidding intensifies.

By Gas Type: Helium Scarcity Alters Investment Patterns

Oxygen led with 34.27% of 2025 revenue, but helium & others will outpace all gases at 10.73% CAGR as MRI operators retrofit recovery systems and shift to conduction-cooled magnets. The medical gases and equipment market size for helium recovery and helium-free MRI is forecast to reach USD 1.8 billion by 2030. Nitrous oxide usage tracks the 6.2% rise in global surgical volumes, while carbon dioxide mirrors laparoscopic adoption at 7.8% growth in 2025. Converters moving to energy-efficient oxygen concentrators in home care reduce liquid oxygen consumption but create a backfill of demand for high-purity oxygen in neonatal and hyperbaric applications.

By Equipment Type: Vacuum & Compressor Systems Capture Growth

Cylinders & tanks still account for 39.72% of equipment value, yet vacuum and compressor systems are set to grow 9.12% annually as robotic procedures stretch suction requirements. NFPA 99 requires redundant pumps capable of 鈥�300 to 鈥�500 mmHg, prompting hospitals to upgrade legacy single-pump installations. Meanwhile, copper pipeline retrofits to ISO 7396-1 standards spur orders for alarm panels and zone valves, but long life cycles mean replacement waves occur only every two decades, affecting the cadence of equipment revenue inside the medical gases and equipment market.

Note: Segment shares of all individual segments available upon report purchase

By Application: Imaging Outpaces Therapy in Growth

Therapy remains the largest application at 47.78% of 2025 demand, yet diagnostic & imaging is the fastest mover with a 9.38% CAGR through 2031. U.S. MRI volumes rose to 42 million scans in 2025, lifting helium demand unless operators shift to helium-free magnets. Pharmaceutical manufacturing consumes increasing volumes of nitrogen for inerting and oxygen for fermentation as FDA continuous-process guidelines gain traction, reinforcing multigas supply contracts.

By End User: Home Healthcare Climbs on Reimbursement Clarity

Hospitals continue to dominate with 54.08% share, but home healthcare鈥檚 8.42% CAGR underscores a payer drive to cut inpatient costs. Medicare now reimburses USD 156 monthly for the first quarter of portable concentrator use, improving economics for DME providers. Tele-monitoring lowers unplanned hospitalizations 18%, offering clear value propositions that accelerate patient uptake and bolster the long-run outlook for the medical gases and equipment market.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America accounted for 41.78% of 2025 revenue, supported by USD 2.1 billion in Medicare and Medicaid outlays for home oxygen equipment. FDA 510(k) clearances for sub-2-kilogram concentrators hit 47 in 2025, highlighting a robust innovation cadence. Section 301 tariffs, ranging from 7.5% to 25%, are prompting U.S. assemblers to source valves from Mexico, although longer lead times test just-in-time models. Canadian provinces are piloting remote oxygen monitoring, with Ontario reporting a 22% reduction in emergency visits in a 2025 trial.

Europe鈥檚 demand benefits from strict ISO 7396-1 compliance requirements and the EMA鈥檚 2025 Annex 1 revision, which mandates real-time oxygen monitoring. Germany, the U.K., France, Italy, and Spain together create more than 60% of regional volume. The U.K.鈥檚 HTM 02-01 guidance obliges annual pipeline integrity tests costing up to USD 13,000 per hospital. Carbon Border Adjustment levies, effective 2026, will add EUR 4-7 per imported cylinder, nudging buyers toward lighter composite models.

Asia-Pacific is the fastest-growing region, albeit from a lower base, at a 11.57% CAGR through 2031. China鈥檚 plan to add 500,000 beds by 2027 and mandate PSA plants in 40% of new hospitals channels vast capex into local generation. India鈥檚 Ayushman Bharat program expanded insurance coverage to 550 million citizens by late 2025, boosting oxygen demand in tier-2 cities. Japan鈥檚 aging society is fueling a surge in nocturnal oxygen therapy, and South Korea raised portable concentrator reimbursement by 8% in 2025.

Middle East & Africa and South America remain smaller but are investing in resilience. Saudi Arabia is spending USD 12 billion to boost hospital capacity by 25% and requires ISO-compliant PSA systems in new builds. In 2025, South Africa purchased 1,200 concentrators for rural clinics. Brazil鈥檚 SUS added home oxygen coverage for 180,000 COPD patients, yet reimbursement trails private insurers by 35%, limiting equipment uptake.